Regulation of RAN translation by PKR and eIF2A-P pathways
AssigneeUniversity of Florida Research Foundation, Inc.
InventorsLaura Ranum, Tao Zu
Life of this patent
Estimating the term…
Abstract
Methods and compositions for modulating repeat non-ATG protein (RAN protein) translation are provided. In some aspects, the disclosure provides methods of inhibiting RAN protein translation by contacting a cell with an effective amount of an inhibitor of eIF2 phosphorylation or an inhibitor of protein kinase R (PKR). In some embodiments, methods described by the disclosure are useful for treating diseases associated with RAN protein translation, such as certain neurodegenerative diseases.
Claims11
A method of inhibiting repeat non-ATG protein (RAN protein) translation, the method comprising contacting a cell expressing a RAN protein with an effective amount of a protein kinase R (PKR) inhibitor.
Dependencies are inferred from the claim text.